Select Date
- >
Loading available days...
Available Slots:
Overview
Dr. Bhuvan Chugh, MBBS, DNB (Medicine), DNB (Medical Oncology), is a Medical Oncologist with over 14 years of experience, practicing at Apollo Hospitals, Delhi. He specializes in precision oncology and comprehensive cancer care for complex malignancies.
Dr. Chugh’s expertise includes Breast Cancer, Thoracic Cancers, Head & Neck Cancers, and Sarcomas (Musculoskeletal Cancers). He is recognized for his work in precision medicine, including pioneering research on CSF genetic sequencing-based treatment for lung cancer. He also manages complex breast cancer cases, including patients who have undergone prior lines of therapy, those with leptomeningeal disease, and patients with multiple co-morbidities.
He focuses on evidence-based systemic treatments, including chemotherapy, targeted therapy, and immunotherapy, tailored to each patient’s unique condition. By collaborating closely with surgical and radiation oncology teams, Dr. Chugh ensures a multidisciplinary approach to cancer care.
Fluent in English and Hindi, he communicates clearly with patients and families, guiding them through treatment options and supportive care. His clinical expertise and patient-centered approach make him a trusted oncologist for breast, thoracic, head and neck cancers, and musculoskeletal malignancies at Apollo Hospitals, Delhi.
Hospital Details
Apollo Hospitals, Delhi
Sarita Vihar, Delhi Mathura Road, New Delhi, DL, 110076
Memberships
- Member, ISMPO-ILLUMINA Precision Oncology Working Group 2024
- Professional Society Memberships: ASCO & ESMO since 2019
- Member, Medical Advisory Board & Co−Researcher at OneCell Diagnostics, Inc.
- Member, Medical Advisory Board − 4Basecare, Genomics and Precision Oncology company based in Bengaluru, India
Awards
- Invited Speaker: SCCHN Preceptorship, Centre Antoine Lacassagne, Nice, France (Nov 2025)
- ESMO Asia 2024 – Best Poster Award (Co-author)
- BusinessWorld 40 Under 40 Awardee
- TEDx Speaker
- ASCO/ESMO abstracts & posters (first author and co-author)
Research and Publication
- Presentations in International Conferences
- OncoTwin Insights: A Clinicogenomic Similarity-Based Decision Support System for Precision Therapy in Lung Cancer (ID 2248). Poster Presentation – ESMO Asia, December 2025, First Author
- Comprehensive germline sequencing and MLPA analysis in breast cancer patients: 4 years of experience from an Indian cancer institute. (First Author, Accepted as Online Only presentation in ASCO Annual Meeting 2025)
- Driving precision oncology in lung cancer: Patient stratification through comprehensive genomic profiling. (Co-Author, Accepted as Poster in ASCO Annual Meeting 2025)
- Landscape of Metastatic Colorectal Cancer (CRC) using Comprehensive circulating tumor DNA (ctDNA) Next Generation Sequencing (NGS) in India: Expanding Beyond RAS and RAF. (Co-Author, Accepted Poster in ASCO GI 2025)
- Genomic mutational profile of breast cancer patients from India through comprehensive next-generation sequencing analysis of circulating tumor DNA. ESMO 2024 – Best Poster Award
- Circulating tumor cells in clinically stable patients demonstrates the conundrum of recurrence with cellular residual disease. ASCO Annual Meeting 2024
- Differences in the Clinicopathological Feature, Prognostic Features and Treatment Outcomes between Molecular Subtypes Among Indian Cohort with Diffuse Large B-Cell Lymphoma - a Single Centre Experience; Blood 134 (Supplement_1):5350-5350, November 2019
- A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre; Blood 134 (Supplement_1):5559-5559, November 2019
- Abstract Publication in BTG2018, 9th International Hematologic Malignancies Conference held in Seoul, South Korea from March 29-31, 2018
- Presentations in National Conferences
- A Prospective Study of Clinico-pathological features, Prognostic factors, and Response rates in Advanced Non-small Cell Lung Cancer Patients Eligible for Chemotherapy - A Single Centre Experience at 37th ICON New Delhi, 2017
- Publications - Chapters in Books
- Systemic Therapies in Hepatocellular Carcinoma (In Publication)
- Chapter titled ‘Key Takeaways from International Guidelines on Gastric Cancer’ in the book ‘Gastric Cancer’ by Springer Healthcare Education
- Chapter titled ‘Biomarkers in Cardiac Disease’ in the book ‘Progress in Medicine’ Volume XXIX, 2015 by Association of Physicians of India-Indian College of Physicians (API-ICP)
- Publications - Journals / Articles
- Malik PS, Baral R, Chugh B, Dawoud E, Forde P, Ghosn M, et al. Excellence in oncology care (EIOC) consensus guidelines on integrating immunotherapy (IO) in resectable non-small cell lung cancer (NSCLC) for the Middle East and Indian subcontinent. Cancer Res Stat Treat. 2025 Oct-Dec;8(4):298-303. doi:10.4103/crst.crst_15_25
- Chugh B, et al. Crossing barriers with CSF-based sequencing for leptomeningeal disease in EGFR mutant NSCLC. J Liq Biopsy. 2025;10:100332
- Investigating the genomic landscape of sarcoma in India: Discoveries from a retrospective observational approach in Cancer Research, Statistics and Treatment, August 2025 (Contributing Author)
- Rastogi, R. et al. (2024) ‘Von Meyerberg complexes: An underrecognized predisposing factor for focal nodular hyperplasia–like lesions’, Indian Journal of Radiology and Imaging [Preprint]. doi:10.1055/s-0044-1801266
- Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective observational study; Cancer Research, Statistics and Treatment 7(2):p 193-205, Apr–Jun 2024
- Clinicohematologic and cytogenetic profile in a rare case of pure erythroid leukaemia; Annals of Hematology 98(3); March 2019
- Myelodysplastic syndromes: Where do we stand? Asian Journal of Oncology. April 2016
- Outcomes of patients presenting with acute coronary syndrome with vitamin D deficiency. Indian Heart Journal. November 2014
- DOTS expansion under the umbrella of IMA: Success story continues along with early teething difficulties. Journal of the Indian Medical Association. July 2008
- Research Work
- Evaluation of circulating tumor DNA (ctDNA) and Circulating Tumor Cells (CTC) for detecting Minimal Residual Disease in Early-Stage Triple-Negative Breast Cancer Post-Neoadjuvant Chemotherapy. REACT Study
- A Phase 3, Randomized, Double-blind, Multicenter Study of MK-1084 in Combination With Pembrolizumab Compared With Pembrolizumab Plus Placebo as First-line Treatment of Participants With KRAS G12C-Mutant, Metastatic NSCLC With PD-L1 TPS ≥ 50% at Max Super Speciality Hospital (Site Verification Ongoing)
- A Registry To Collect Characteristics And Outcomes From Patients With Solid Tumors Profiled With A Next-Generation Sequencing Test (WAYFIND-R)
Special Interests
- Breast, Thoracic, Head & Neck Cancers and Sarcomas (Musculoskeletal Cancers)
- Precision Medicine with pioneer publication on CSF genetic sequencing based treatment in Lung Cancer
- Treatment of complex breast cancer cases, including post initial lines of therapy, those with leptomeningeal disease, and those with co-morbidities
Best Hospital Near me Chennai